(19)
(11) EP 0 951 559 A1

(12)

(43) Date of publication:
27.10.1999 Bulletin 1999/43

(21) Application number: 97933544.0

(22) Date of filing: 09.07.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 39/ 00( . )
C07K 14/ 47( . )
A61K 48/ 00( . )
 A61K 35/ 76( . )
A61P 35/ 00( . )
C12N 7/ 00( . )
(86) International application number:
PCT/US1997/012546
(87) International publication number:
WO 1998/004728 (05.02.1998 Gazette 1998/05)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 25.07.1996 US 19960686281

(71) Applicants:
  • THERION BIOLOGICS CORPORATION
    Cambridge, MA 02142 (US)
  • THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Rockville, MD 20852-3804 (US)

(72) Inventors:
  • ROSENBERG, Steven, A.
    Potomac, MD 20854 (US)
  • RESTIFO, Nicholas
    Washington, DC 20009 (US)
  • PANICALI, Dennis, L.
    Acton, MA 02139 (US)

(74) Representative: Dean, John Paul, et al 
Withers & Rogers, Goldings House, 2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)

   


(54) RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST TUMOR-ASSOCIATED ANTIGENS